Skip to main content
. 2014 Apr 8;3(4):909–918. doi: 10.1002/cam4.244

Figure 4.

Figure 4

Kaplan–Meier plot of the survival in patients with ovarian carcinoma. Patients are grouped according to immunohistochemistry (IHC) staining (positive or negative) of the Wilms' tumor gene 1 (WT1). (A) Overall survival (OS) for 50 patients studied. (B) Progression-free survival (PFS) for patients included in the study. (C) OS for patients with serous ovarian carcinoma. (D) PFS for patients with serous ovarian carcinoma. (E) PFS for patients with nonserous subtypes. (F) OS for patients with nonserous subtypes.